Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Population pharmacokinetics of levofloxacin in intensive care patients with severe community-acquired pneumonia
2011-002177-34Phase 4Completed
- Sponsor
- Centre hospitalier universitaire de Toulouse
- Start
- Sep 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of levofloxacin in community-acquired pneumonia (CAP) and bacterial pneumonia, sponsored by Centre hospitalier universitaire de Toulouse. Started Sep 2011; status: completed.
02
Drugs
levofloxacin
03
Conditions
community-acquired pneumonia (CAP)bacterial pneumonia
Beyond the preview
Go deeper on 2011-002177-34.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-002177-34.